Drugs Made In America Acquisition II Corp.
DMIIR- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002040475
No open-market purchases or sales by Drugs Made In America Acquisition II Corp. insiders were filed in the last 90 days; 63 institutions reported holding it in 13F filings for Q2 2026, worth $3.25M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Drugs Made In America Acquisition II Corp. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 58 | 63 | +5 |
| Shares | 39.9M | 41.1M | +1.15M (+2.9%) |
| Value | $3.19M | $3.25M | +$55.1K (+1.7%) |
New holders (5)
Institutions that held Drugs Made In America Acquisition II Corp. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| TIG Advisors, LLC | 500,000 | $40.0K | 0.00% |
| SkyView Investment Advisors, LLC | 250,000 | $20.0K | 0.02% |
| Kepos Capital LP | 188,400 | $15.0K | 0.02% |
| StoneX Group Inc. | 100,000 | $7.96K | 0.00% |
| SRS Capital Advisors, Inc. | 65,990 | $5.28K | 0.00% |
Sold out (0)
Institutions that held Drugs Made In America Acquisition II Corp. at the end of Q1 2026 and filed for Q2 2026 without it.
None.